Project objectives:
The National Institute of Virology and Bacteriology (NIVB) aims to make discoveries in infectious diseases that will improve human health, develop safe and effective antiviral and antibacterial therapies, and prepare platforms for future drug discovery and development against viruses and bacteria with pandemic potential.
NIVB pursues cutting-edge research in the areas of (1) pathogen-host interactions, (2) immunity against viruses and bacteria, and (3) treatment of viral and bacterial infections. By working with pathogens that are relevant to current clinical practice, as well as emerging viruses and bacteria, the Institute’s research groups will be able to provide the expertise and facilities to study new pathogens that may spread to the human population in the future. The NIVB will thus become a national authority and knowledge partner for public authorities in this respect.
EXCELES projects are funded by a grant from the Ministry of Education, Youth and Sports under the EXCELES programme, which aims to support excellent research in priority areas of public interest in the health sector. The EXCELES programme is funded by the European Union through the Recovery and Resilience Facility (RRF) – NextGeneretionEU.
| Project number | LX22NPO5103 |
| Beneficiary | Institute of Organic Chemistry and Biochemistry of the CAS, v.v.i. |
| Principal investigator | RNDr. PhDr. Zdeněk Hostomský, CSc. |
| Start of the project | 06/2022 |
| End of the project | 12/2025 |
| Number of co-beneficiaries (coinvestigators) | 8, IMIC is a co-beneficiary (coinvestigator) |
| Coinvestigator for IMIC | prof. Ing. Peter Šebo, CSc. |